# A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia

> **NCT00154089** · PHASE1,PHASE2 · COMPLETED · sponsor: **Erimos Pharmaceuticals** · enrollment: 8 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DRUG:** EM-1421

## Key facts

- **NCT ID:** NCT00154089
- **Lead sponsor:** Erimos Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2006-04
- **Final completion:** 2006-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-02-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154089, "A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00154089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*